Eagle Global Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Eagle Global Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,398	Closed	-$121K	–	418
2016 Q1	$121K	Hold	10,398	–	–	﹤0.01%	344
2015 Q4	$121K	Sell	10,398 -11,200	-52%	-$142K	﹤0.01%	344
2015 Q3	$264K	Buy	21,598 +9,788	+83%	+$125K	0.01%	291
2015 Q2	$111K	Buy	+11,810	New	+$109K	﹤0.01%	365
2014 Q3	–	Sell	-37,050	Closed	-$266K	–	395
2014 Q2	$266K	Buy	37,050 +7,850	+27%	+$62.5K	0.01%	265
2014 Q1	$295K	Buy	+29,200	New	+$269K	0.01%	228

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Eagle Global Advisors's BEAT Position: Q2 2016 in Review

Eagle Global Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2016, closing a stake of 10,398 shares — an estimated $121K sold.

Eagle Global Advisors first reported a position in BEAT in Q1 2014 and held it in 6 quarters. The position peaked at $295K in Q1 2014. 139 funds tracked by Wall St. Rank hold BEAT as of Q2 2016.

Eagle Global Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2016 after selling out during the quarter.
Eagle Global Advisors sold 10,398 BioTelemetry, Inc. shares in Q2 2016, an estimated $121K.
Eagle Global Advisors first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 6 quarters.
Eagle Global Advisors's BioTelemetry, Inc. position peaked at $295K in Q1 2014.
139 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2016.

Based on Eagle Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.